WILLOW BIOSCIENCES INC (WLLW.CA) Stock Fundamental Analysis

TSX:WLLW • CA97111B4047

0.17 CAD
+0.01 (+6.25%)
Last: Oct 3, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

WLLW gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 22 industry peers in the Biotechnology industry. Both the profitability and financial health of WLLW have multiple concerns. While showing a medium growth rate, WLLW is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year WLLW has reported negative net income.
  • In the past year WLLW has reported a negative cash flow from operations.
  • WLLW had negative earnings in each of the past 5 years.
  • In the past 5 years WLLW always reported negative operating cash flow.
WLLW.CA Yearly Net Income VS EBIT VS OCF VS FCFWLLW.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • The Return On Assets of WLLW (-179.33%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -179.33%
ROE N/A
ROIC N/A
ROA(3y)-175.17%
ROA(5y)-139.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WLLW.CA Yearly ROA, ROE, ROICWLLW.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for WLLW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WLLW.CA Yearly Profit, Operating, Gross MarginsWLLW.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100K -200K -300K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • WLLW does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for WLLW has been increased compared to 1 year ago.
  • The number of shares outstanding for WLLW has been increased compared to 5 years ago.
  • Compared to 1 year ago, WLLW has a worse debt to assets ratio.
WLLW.CA Yearly Shares OutstandingWLLW.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
WLLW.CA Yearly Total Debt VS Total AssetsWLLW.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -57.93, we must say that WLLW is in the distress zone and has some risk of bankruptcy.
  • WLLW's Altman-Z score of -57.93 is on the low side compared to the rest of the industry. WLLW is outperformed by 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -57.93
ROIC/WACCN/A
WACC8.82%
WLLW.CA Yearly LT Debt VS Equity VS FCFWLLW.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 1.01 indicates that WLLW should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.01, WLLW perfoms like the industry average, outperforming 45.83% of the companies in the same industry.
  • WLLW has a Quick Ratio of 1.01. This is a normal value and indicates that WLLW is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.01, WLLW is in line with its industry, outperforming 45.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01
WLLW.CA Yearly Current Assets VS Current LiabilitesWLLW.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.95% over the past year.
  • Looking at the last year, WLLW shows a very strong growth in Revenue. The Revenue has grown by 570.53%.
  • Measured over the past years, WLLW shows a very strong growth in Revenue. The Revenue has been growing by 229.77% on average per year.
EPS 1Y (TTM)66.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.56%
Revenue 1Y (TTM)570.53%
Revenue growth 3Y229.77%
Revenue growth 5YN/A
Sales Q2Q%3349.02%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WLLW.CA Yearly Revenue VS EstimatesWLLW.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 1M 2M 3M 4M
WLLW.CA Yearly EPS VS EstimatesWLLW.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WLLW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WLLW.CA Price Earnings VS Forward Price EarningsWLLW.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WLLW.CA Per share dataWLLW.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • WLLW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

WILLOW BIOSCIENCES INC

TSX:WLLW (10/3/2025, 7:00:00 PM)

0.17

+0.01 (+6.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-11
Earnings (Next)11-10
Inst Owners19.06%
Inst Owner ChangeN/A
Ins Owners39.31%
Ins Owner ChangeN/A
Market Cap107.00M
Revenue(TTM)6.37M
Net Income(TTM)-4.15M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 16.8
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -179.33%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-175.17%
ROA(5y)-139.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.75
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z -57.93
F-Score4
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)20.3%
Cap/Depr(5y)29.57%
Cap/Sales(3y)45.39%
Cap/Sales(5y)2299.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)570.53%
Revenue growth 3Y229.77%
Revenue growth 5YN/A
Sales Q2Q%3349.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y71.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.21%
OCF growth 3YN/A
OCF growth 5YN/A

WILLOW BIOSCIENCES INC / WLLW.CA FAQ

What is the ChartMill fundamental rating of WILLOW BIOSCIENCES INC (WLLW.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to WLLW.CA.


What is the valuation status for WLLW stock?

ChartMill assigns a valuation rating of 0 / 10 to WILLOW BIOSCIENCES INC (WLLW.CA). This can be considered as Overvalued.


Can you provide the profitability details for WILLOW BIOSCIENCES INC?

WILLOW BIOSCIENCES INC (WLLW.CA) has a profitability rating of 0 / 10.